Pigmentation in basal cell carcinoma involves enhanced endothelin-1 expression

Experimental Dermatology

Volumn 14, Issue 7, 2005, Pages 528-534

  Lan, Cheng Che E ^a   Wu, Ching Shuang ^b   Cheng, Chiu Min ^a   Yu, Chia Li ^c   Chen, Gwo Shing ^a   Yu, Hsin Su ^c  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Basal cell carcinoma; Endothelin 1; Melanocytes; Pigmentation; UVB

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; MELANIN; NERVE GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BASAL CELL CARCINOMA; CANCER CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; HYPERPIGMENTATION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MELANOCYTE; MELANOGENESIS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN SECRETION; SUPERNATANT; ULTRAVIOLET B RADIATION;

CARCINOMA, BASAL CELL; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; ENDOTHELIN-1; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MELANOCYTES; NERVE GROWTH FACTOR; PIGMENTATION; SKIN NEOPLASMS;

EID: 21244458414     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0906-6705.2005.00320.x     Document Type: Article

References (36)

1. Grimwood R E, Siegle R J, Ferris C F. The biology of basal cell carcinoma - a revisit and recent developments. J Dermatol Surg Oncol 1986: 12: 805-808.
2. Ikeda S, Kiyohara Y, Mizutani H. Comparative aspects of melanoma and non-melanoma skin cancer in Japan. J Invest Dermatol 1989: 92: 204s-209s.
3. Abreo F, Sanusi I D. Basal cell carcinoma in North American blacks: clinical and histopathologic study of 26 patients. J Am Acad Dermatol 1991: 25: 1005-1011.
4. Yaar M, Gilchrest B A. Human melanocyte growth and differentiation: a decade of new data. J Invest Dermatol 1991: 97: 611-617.
5. Jimbow K, Quevedo W C, Prota G, Fitzpatrick T B. Biology of melanocytes. In: Freedberg I M, Eisen A Z, Wolff K et al., eds. Dermatology in general medicine. New York: McGraw-Hill, 1999: 192-219.
6. Ono T, Kitoh M, Kuuriya N. Characterization of basal cell epithelioma in the Japanese. J Dermatol 1982: 9: 291-300.
7. Kikuchi A, Shimizu H, Nishikawa T. Clinical and histopathological characteristics of basal cell carcinoma in Japanese patients. Arch Dermatol 1996: 132: 320-324.
8. Maloney M E, Jones D B, Sexton F M. Pigmented basal cell carcinoma: investigation of 70 cases. J Am Acad Dermatol 1992: 27: 74-78.
9. Betti R, Inselvini E, Moneghini L, Crosti C. Giant basal cell carcinomas: report of four cases and considerations. J Dermatol 1997: 24: 317-321.
10. Bleehen S S. Disorders of skin colour. In: Champion R H, Burton J L, Ebling F J G, eds. Textbook of dermatology. Oxford: Blackwell Science, 1998: 1753-1815.
11. Kirkham N. Tumors and cysts of epidermis. In: Elder D, Elenitsas R, Jaworsky C, Johnson B Jr, eds. Lever's histopathology of the skin. Philadelphia: Lippincott-Raven, 1997: 685-731.
12. Lao L M, Kumakiri M, Kiyohara T et al. Subpopulations of melanocytes in pigmented basal cell carcinoma: a quantitative, ultrastructrual, investigation. J Cutan Pathol 2001: 28: 34-43.
13. Sakuraba K, Hayashi N, Kawashima M, Imokawa G. Down-regulated PAP-2 is associated in part with interrupted melanosome transfer in pigmented basal cell epithelioma. Pigment Cell Res 2004: 17: 371-378.
14. Manaka I, Kadono S, Kawashima M et al. The mechanism of hyperpigmentation in seborrheic keratosis involves the high expression of endothelin- converting enzyme-1α and TNF-α, which stimulate secretion of endothelin 1. Br J Dermatol 2001: 145: 895-903.
15. Vural P, Erzengin D, Canbaz M, Selcuki D. Nitric oxide and endothelin-1,2 in actinic keratosis and basal cell carcinoma: changes in nitric oxide/endothelin ratio. Int J Dermatol 2001: 40: 704-708.
16. Chiang L C, Chiang W, Yu H S et al. Establishment and characterization of continuous human basal cell carcinoma cell line from facial skin: cytological behavior of early passages. Kaohsiung J Med Sci 1994: 10: 170-176.
17. Li Y L, Yu C L, Yu H S. IgG anti-melanocyte antibodies purified from patients with active vitiligo induce HLA-DR and intercellular adhesion molecule-1 expression and an increase in interleukin-8 release by melanocytes. J Invest Dermatol 2000: 115: 969-973.
18. Yen H T, Chiang L C, Wen K H et al. The expression of cytokines by an established basal cell carcinoma cell line compared with cultured normal keratinocytes. Arch Dermatol Res 1996: 288: 157-161.
19. Scudiero D A, Shoemaker R H, Paul K D et al. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 1998: 48: 4827-4833.
20. Hu D N, McCormick S A, Orlow S J et al. Melanogenesis by human uveal melanocytes in vitro. Invest Ophthalmol Vis Sci 1995: 36: 931-938.
21. Morelli J G, Yohn J J, Zekman T, Norris D A. Melanocyte movement in vitro: role of matrix proteins and integrin receptors. J Invest Dermatol 1993: 101: 605-608.
22. Yu H S, Wu C S, Yu C L et al. Helium-neon laser irradiation stimulates migration and proliferation in melanocytes and induces repigmentation in segmental-type vitiligo. J Invest Dermatol 2003: 120: 56-64.
23. Neitmann M, Alexander M, Brinckmann J, Schlenke P, Tronnier M. Attachment and chemotaxis of melanocytes after ultraviolet irradiation in vitro. Br J Dermatol 1999: 141: 794-801.
24. Jee SH, Shen S C, Chiu H C et al. Overexpression of interleukin-6 in human basal cell carcinoma cell lines increases anti-apoptotic activity and tumorigenic potency. Oncogene 2001: 20: 198-210.
25. Halaban R, Langdon R, Birchall N et al. Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes. J Cell Biol 1998: 107: 1611-1619.
26. Yada Y, Higuchi K, Imokawa G. Effects of endothelins on signal transduction and proliferation in human melanocytes. J Biol Chem 1991: 266: 18352-18357.
27. Yaar M, Grossman K, Eller M, Gilchrest B A. Evidence for nerve growth factor-mediated paracrine effects in human epidermis. J Cell Biol 1991: 115: 821-828.
28. Imokawa G, Yada Y, Miyagishi M. Endothelins secreted from human keratinocytes are intrinsic mitogens for human melanocytes. J Biol Chem 1992: 267: 24675-24680.
29. Marks R. An overview of skin cancers: incidence and causation. Cancer 1995: 75: 607-612.
30. Ashby M A, Smith J, Ainslie J, McEwan L. Treatment of nonmelanoma skin cancer at a large Australian center. Cancer 1989: 63: 1863-1871.
31. Tsuboi R, Sato C, Oshita et al. Ultraviolet B irradiation increases endothelin-1 and endothelin receptor expression in cultured human keratinocytes. FEBS Letter 1995: 371: 188-190.
32. Heckmann M, Zogelmeier F, Konz B. Frequency of facial basal cell carcinoma does not correlate with site-specific UV exposure. Arch Dermatol 2002: 138: 1494 1497.
33. Tsuboi R, Sato C, Shi C et al. Endothelin-1 acts as an autocrine growth factor for normal melanocytes. J Cell Physiol 1994: 159: 213-220.
34. Imokawa G, Miyagishi M, Yada Y. Endothelin-1 as a new melanogen: coordinated expression of its gene and the tyrosinase gene in UVB-exposed human epidermis. J Invest Dermatol 1995: 105: 32-37.
35. Imokawa G, Kobayashi T, Miyagishi M et al. The role of endothelin-1 in epidermal hyperpigmentation and signaling mechanisms of mitogenesis and melanogenesis. Pigment Cell Res 1997: 10: 218-228.
36. Kodono S, Manaka I, Kawashima M, Kobayashi T, Imokawa G. The role of the epidermal endothelin cascade in the hyperpigmentation mechanism of lentigo senilis. J Invest Dermatol 2001: 116: 571-577.